1-5 of 5
Ashwini Shewade
Close
Sort by
Journal Articles

Real-World Incidence, Characteristics and Management of Cytokine Release Syndrome Induced By Chimeric Antigen Receptor T-Cell Therapy across Hematologic Malignancies

Nayan Chaudhary, Sumi Roy, Chu-Fang Lin, Maneesh Tandon, Antonia Kwan, Peter Kuebler, Ashwini Shewade
Journal: Blood
Blood (2023) 142 (Supplement 1): 5150.
https://doi.org/10.1182/blood-2023-174921
Published: 2023
Journal Articles

An External Control for Mosunetuzumab Using Real-World Data in Follicular Lymphoma in the Third or Subsequent Lines of Systemic Therapy

Sarah F. McGough, Natasha Shamas, Jue Wang, Mahmoud Jaber, Binay Swarup, Marie-Helene Blanchet Zumofen, Bertrand Lautié, Joana Parreira, Michael C. Wei, Ashwini Shewade
Journal: Blood
Blood (2022) 140 (Supplement 1): 3658–3660.
https://doi.org/10.1182/blood-2022-159640
Published: 2022
Journal Articles

Treatment Patterns and Outcomes in Patients with Relapsed/Refractory Follicular Lymphoma Who Received Third Line Therapy at the Christie NHS Foundation Trust in the UK

Kim Linton, Cristina Julian, Adam Gibb, Ellie White, Emma-Frances Armstrong, Yun Li, Yutong Liu, Ashwini Shewade, John Radford
Journal: Blood
Blood (2021) 138 (Supplement 1): 5011.
https://doi.org/10.1182/blood-2021-148490
Published: 2021
Journal Articles

Unmet Medical Need Among Elderly Patients with Previously Untreated DLBCL Characterized Using Real-World Data in the United States

Ashwini Shewade, Adam J Olszewski, MD, Nelson Pace, Andy Surinach, MPH, Gila Sellam, Lars Mueller, Carol O'Hear
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–8.
https://doi.org/10.1182/blood-2020-136271
Published: 2020
Journal Articles

Cost-Effectiveness of Rituximab Post CVP Induction for the Treatment of Low-Grade NHL.

John C. Hornberger, MD, MS, Carolina Reyes, PhD, Ashwini Shewade, MS, David Loecke, PhD, Nancy Valente, MD
Journal: Blood
Blood (2007) 110 (11): 4486.
https://doi.org/10.1182/blood.V110.11.4486.4486
Published: 2007